Piper Jaffray analyst David Amsellem boosted his price target on Neutral-rated Allergen (NYSE: AGN) from $109 to $164 amid takeover ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE